810154P
16:0-12:0 NBD PE
Manufacturer: Sigma Aldrich
CAS Number: 328946-26-5
Synonym(S): 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoethanolamine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810154P-1-MG | In Stock | ₹ 32,096.13 |
810154P - 1 MG
In Stock
Quantity
1
Base Price: ₹ 32,096.13
GST (18%): ₹ 5,777.303
Total Price: ₹ 37,873.433
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (810154P-1mg)pkg of 5 × 1 mg (810154P-5mg)
manufacturer/tradename
Avanti Polar Lipids 810154P
shipped in
dry ice
storage temp.
−20°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 328946-26-5 | 16:0-12:0 NBD PE | A2B Chem | -- |
Related Products
Description
- General description: N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) phosphoethanolamine (NBD PE) is a fluorescent probe localized at the membrane interface.[1][2] It possess fluorescent NBD label attached to the headgroup of phosphatidylethanolamine (PE).[2] PE is the parent compound for phosphatidylcholine and phosphatidylethanolamine synthesis[3] and is mostly enriched in brain.[4]
- Application: 16:0-12:0 NBD PE has been used in lipid extraction assay and in vitro phospholipid fluorescence resonance energy transfer (FRET) assays.[5] It is suitable for the determination of enzyme substrate specificity of lipoteichoic acid synthase (LtaS).[6][7][6]
- Biochem/physiol Actions: Phosphoethanolamine (PE) plays a vital role in the prevention of tumor proliferation.[3] N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) phosphoethanolamine (NBD PE) monitors the Red edge excitation shift (REES) phenomenon with the unique motional and dielectric properties it possesses.[1]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810154P-1mg)
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810154P-1mg)pkg of 5 × 1 mg (810154P-5mg)
manufacturer/tradename: Avanti Polar Lipids 810154P
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810154P-1mg)pkg of 5 × 1 mg (810154P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 810154P
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810157P-1mg)pkg of 5 × 1 mg (810157P-5mg)pkg of 5 × 2 mg (810157P-10mg)
manufacturer/tradename: Avanti Polar Lipids 810157P
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810157P-1mg)pkg of 5 × 1 mg (810157P-5mg)pkg of 5 × 2 mg (810157P-10mg)
manufacturer/tradename:
Avanti Polar Lipids 810157P
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810158C-1mg)pkg of 5 × 1 mL (810158C-5mg)
manufacturer/tradename: Avanti Polar Lipids 810158C
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810158C-1mg)pkg of 5 × 1 mL (810158C-5mg)
manufacturer/tradename:
Avanti Polar Lipids 810158C
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810158P-1mg)pkg of 5 × 1 mg (810158P-5mg)pkg of 5 × 2 mg (810158P-10mg)
manufacturer/tradename: Avanti Polar Lipids
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810158P-1mg)pkg of 5 × 1 mg (810158P-5mg)pkg of 5 × 2 mg (810158P-10mg)
manufacturer/tradename:
Avanti Polar Lipids
shipped in:
dry ice
storage temp.:
−20°C